Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article
Causes of Death and Incidence of Life-support Techniques Limitations in Oncological Patients Dying in the ICU: A Retrospective Study
Anne-Pascale Meert*, Séverine Dept, Thierry Berghmans and Jean-Paul SculierDepartment of Intensive Care and Thoracic Oncology and Jules Bordet Institute, Centre of tumors of the Free University of Brussels (ULB), Brussels, Belgium
- *Corresponding Author:
- Dr. Anne-Pascale Meert
Department of Intensive Care and Thoracic Oncology and Jules Bordet Institute
Centre of tumors of the Free University of Brussels (ULB)
Brussels, Belgium
Tel: +322 541 3191
Fax: +322 534 3756
E-mail: ap.meert@bordet.be
Received date: December 07, 2011; Accepted date: February 28, 2012; Published date: March 01, 2012
Citation: Meert AP, Dept S, Berghmans T, Sculier JP (2012) Causes of Death and Incidence of Life-support Techniques Limitations in Oncological Patients Dying in the ICU: A Retrospective Study. J Palliative Care Med 2:107.doi:10.4172/2165- 7386.1000107
Copyright: © 2012 Meert AP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: Our objectives were to determine, for cancer patients dying in the ICU, the reasons for admission, the causes of death and the impact of life-support techniques limitations (LSTL).
Methods: This is a retrospective study including only cancer patients dying in the ICU .
Results: From 1 st January 2008 to 31 st December 2009, 658 patients were admitted in the ICU, 71 of whom had neoplastic disease and ultimately died after admission for a medical/surgical complications. Their principal characteristics were: men/women 38/33, median age 57 years, solid/haematological tumours 46/25. Solid tumours were mainly presenting at a metastatic stage (93.5%). Out of the 25 haematological patients, 6 were allograft recipients. The most frequent causes of admission were respiratory failure (36.6%) and infection (47.9%). Infection was the cause of death in 53.5%. Twenty-one patients had LSTL at or during the first 24 hours of ICU admission, especially because of cancer progression. Another 33 had LSTL later due to clinical deterioration. Seventeen patients did not receive any LSTL; all died with mechanical invasive ventilatory support. Early LSTL is mainly related to cancer progression while late LSTL are often decided in front of unfavourable evolution of the acute complications in patients with better cancer prognosis.
Conclusions: This study, restricted to cancer patients dying in the ICU, showed that respiratory failure and infec - tion were the leading cause of ICU admission. Infection was the first cause of death. The majority of the cancer patients dying in the ICU had LSTL. All patients with no LSTL died with mechanical invasive ventilatory support. Functional stages, the existence of an oncological treatment project and the evolution of complication leading to ICU admission have a major impact in the decision of LSTL.
